Scientists and doctors in Israel used an unusual technique for the treatment of fibroadenoma of the breast. Method of cryoablation normally uses to fight tumors of the kidney and prostate. But the company IceCure Medical in Israel uses it for the treatment of breast cancer.
Surgeons the USA for a long time apply the device IceSense3, developed in Israel, to remove fibroadenomas — benign breast tumors. It allows you to do this painlessly and quickly. The next step may be the application of this technique for malignant neoplasms.
The use of this device allowed us to make a significant step forward. Previously, patients prefer to be observed at the doctor for years, afraid of scars and surgery in General. Now the treatment leaves no scars and does not bring pain, which significantly accelerates the recovery of women.
The procedure takes less than 10 minutes. The woman in the tumor tissue injected probe (hollow needle). Then under ultrasound, the tumor is destroyed by the exposure to low temperature (-170°C). The whole operation is performed under local anesthesia, so the patient feels nothing.
Now we are working on the introduction of IceSense3 as a means of dealing with malignant tumors. Now for these purposes there is a procedure called mastectomy, and it means surgical removal of the tumor.
First IceSense3 used for removal of malignant neoplasms of the breast in 2012. The trial enrolled four patients. Tumors of small size were successfully removed. Now, such operations are expected 26 women.
The device will soon be used in the United States. He received a certificate of compliance with European standards (CE), but so far the European Union has not been used.
Increased demand for the operation is due to just the fact that he struggles with tumors but smaller in size. Earlier there were very few women who learned about the disease at an early stage. Now, however, the patient often conduct a breast exam and increasingly present with the disease at the beginning.
This technique has attracted the interest of scientists at a conference in Phoenix in 2012, brought together in one hall leading surgeons mamalahoa of America.
